Skip to main content
HCTI
NASDAQ Technology

Healthcare Triangle Issues 12.5M Shares, Boosting MVLS to $23.9M to Meet Nasdaq's New $5M Listing Standard

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.58
Mkt Cap
$3.305M
52W Low
$1.463
52W High
$1,225.068
52W Position info
8.0% above low
Off High info
100% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

HCTI is trading near its 52-week low of $1.463 (8.0% above the low) on light trading volume (0.3× avg).

Summary

Healthcare Triangle issued 12.5 million shares to close two legacy M&A deals, boosting its MVLS to $23.9 million and providing a cushion above Nasdaq's new $5 million minimum listing standard.


Key Events · Financing and Capital Events · HCTI

  • 12.5M Shares Issued

    Issued 9,718,373 shares for the Teyame Transaction and 2,828,167 shares for the SecureKloud Securities Exchange, totaling 12,546,540 shares.

  • MVLS Boost to $23.9M

    Post-issuance, total shares outstanding reached 14,644,322, yielding an MVLS of approximately $23.9 million based on a $1.63 closing price, well above Nasdaq's new $5 million minimum.

  • Nasdaq Compliance Strategy

    The company explicitly tied the issuance to strengthening compliance with Nasdaq's newly effective $5 million MVLS continued listing standard, reducing delisting risk.

  • Massive Dilution

    Shares outstanding increased from roughly 2.1 million to 14.6 million, representing dilution of approximately 600% for existing holders, though the transactions were previously approved.


Analysis · HCTI · Technology

Healthcare Triangle completed two previously approved transactions, issuing 12.5 million shares and increasing total shares outstanding to 14.6 million. The issuance was framed as a strategic move to strengthen compliance with Nasdaq's new $5 million Market Value of Listed Securities (MVLS) requirement, with the company's MVLS now at approximately $23.9 million. While the transactions were already approved by shareholders, the exact share counts and the explicit link to Nasdaq compliance are new material details. The massive dilution — shares outstanding nearly sextupled — is offset by the survival benefit of maintaining Nasdaq listing, which is critical for a micro-cap company with a history of financing challenges.

At the time of this filing, HCTI was trading at $1.58 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.46 to $1,225.07. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HCTI - Latest Insights

HCTI
Jul 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.77
Real-time Price: $1.60 info
Change: -$0.170 (-10%) info
Market Cap: $3.305M info
HCTI
Jul 16, 2026, 4:05 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $1.60 info
Change: -$0.290 (-15%) info
Market Cap: $3.305M info
HCTI
Jul 06, 2026, 5:23 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.93
Real-time Price: $1.60 info
Change: -$0.330 (-17%) info
Market Cap: $3.305M info
HCTI
Jun 26, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
10
Price at Filing: $2.62
Real-time Price: $1.60 info
Change: -$1.02 (-39%) info
Market Cap: $3.305M info
HCTI
Jun 26, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $1.60 info
Change: -$0.440 (-22%) info
Market Cap: $3.305M info